{"id":"NCT00409682","sponsor":"Abbott","briefTitle":"Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease","officialTitle":"A Multi-Center, Double-Blind Study to Evaluate the Safety, Efficacy and Pharmacokinetics of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-04","primaryCompletion":"2010-05","completion":"2010-05","firstPosted":"2006-12-11","resultsPosted":"2011-08-04","lastUpdate":"2011-08-04"},"enrollment":192,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Crohn's Disease"],"interventions":[{"type":"BIOLOGICAL","name":"Adalimumab","otherNames":["ABT-D2E7, adalimumab, Humira"]},{"type":"BIOLOGICAL","name":"Adalimumab","otherNames":["ABT-D2E7, adalimumab, Humira"]},{"type":"BIOLOGICAL","name":"Adalimumab","otherNames":["ABT-D2E7, adalimumab, Humira"]}],"arms":[{"label":"Open-label adalimumab (Week 0 to Week 4)","type":"ACTIVE_COMPARATOR"},{"label":"Low-Dose Adalimumab: 20 mg or 10 mg eow (Week 4 to Week 52)","type":"ACTIVE_COMPARATOR"},{"label":"High-Dose Adalimumab: 40 mg or 20 mg eow (Week 4 to Week 52)","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine Efficacy, Pharmacokinetics, and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease","primaryOutcome":{"measure":"Percent of Participants With Clinical Remission as Defined by Pediatric Crohn's Disease Activity Index (PCDAI) Score â‰¤ 10 at Week 26","timeFrame":"Week 26","effectByArm":[{"arm":"Low-Dose Adalimumab: 20 mg or 10 mg Eow (Week 4 to Week 52)","deltaMin":28.4,"sd":null},{"arm":"High-Dose Adalimumab: 40 mg or 20 mg Eow (Week 4 to Week 52)","deltaMin":38.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.075"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":45,"countries":["United States","Belgium","Canada","Czechia","France","Netherlands","Poland","United Kingdom"]},"refs":{"pmids":["30054164","29939254","22562021"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":192},"commonTop":["HEADACHE","CROHN'S DISEASE","NAUSEA","UPPER RESPIRATORY TRACT INFECTION","NASOPHARYNGITIS"]}}